Details for Patent: 8,802,624
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,802,624 protect, and when does it expire?
Patent 8,802,624 protects NOCDURNA and is included in one NDA.
This patent has forty-three patent family members in twenty-nine countries.
Summary for Patent: 8,802,624
| Title: | Methods of treatment using orodispersible desmopressin pharmaceutical formulations |
| Abstract: | Described herein are methods of treating diseases or conditions such as incontinence, primary nocturnal enuresis (PNE), nocturia, and central diabetes insipidus, by administering desmopressin acetate in an orodispersiblc solid dosage form that disintegrates in the mouth within 10 seconds and includes an amount of desmopressin acetate, measured as the free base, of from 10 to 600 .mu.g. |
| Inventor(s): | Nilsson; Anders (Lund, SE), Lindner; Hans (Leichlingen, DE), Wittendorff; Jorgen (Hvidovre, DK) |
| Assignee: | Ferring B.V. (Hoofddorp, NL) |
| Application Number: | 13/110,619 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,802,624 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,802,624
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | See Plans and Pricing | ||||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,802,624
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0210397.6 | May 7, 2002 |
| PCT/IB02/04036 | Sep 20, 2002 | |
International Family Members for US Patent 8,802,624
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039092 | See Plans and Pricing | |||
| Argentina | 039794 | See Plans and Pricing | |||
| Argentina | 107948 | See Plans and Pricing | |||
| Austria | 333886 | See Plans and Pricing | |||
| Australia | 2002337419 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
